美国三级医疗中心脑脊液鸟枪法宏基因组测序临床效用回顾性分析
该研究回顾性分析了2017年12月至2019年12月送至外部参考实验室的脑脊液鸟枪法宏基因组测序结果。Mayo Clinic患者53例中9例(17%)阳性,6例判为可能污染;总体阳性率15%(12/80),其中58%(7/12)与临床表现不符,潜在病原体检出率低且阳性结果临床意义常不明确。
要点
- 脑脊液mNGS总体阳性率15%,其中58%阳性结果与临床表现不符。
- 检测多用于诊断不明及考虑免疫治疗的患者,阳性结果临床意义常不明确。
核心结论
- 脑脊液鸟枪法宏基因组测序在潜在病原体检测中阳性率低,且阳性结果常临床意义不明确。
主要发现
- Mayo Clinic患者53例中9例(17%)阳性,6例判为可能污染,潜在病原体包括布尼亚病毒、人疱疹病毒7型和肠道病毒D-68,仅2例影响诊疗。
- 68例阴性结果中10例有注释:高DNA背景5例、高RNA背景1例、RNA读长深度不足3例、外源RNA质控失败1例。
- 总体阳性率15%(12/80),其中58%(7/12)判为与患者临床表现不符。
临床怎么用
- 检测常用于诊断不明及考虑免疫治疗的患者,但阳性结果需结合临床谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Shotgun metagenomic sequencing can detect nucleic acids from bacteria, fungi, viruses, and/or parasites in clinical specimens; however, little data exist to guide its optimal application to clinical practice. We retrospectively reviewed results of shotgun metagenomic sequencing testing requested on cerebrospinal fluid samples submitted to an outside reference laboratory from December 2017 through December 2019. Of the 53 samples from Mayo Clinic patients, 47 were requested by neurologists, with infectious diseases consultation in 23 cases. The majority of patients presented with difficult-to-diagnose subacute or chronic conditions. Positive results were reported for 9 (17%) Mayo Clinic patient samples, with 6 interpreted as likely contamination. Potential pathogens reported included bunyavirus, human herpesvirus 7, and enterovirus D-68, ultimately impacting care in two cases. Twenty-seven additional samples were submitted from Mayo Clinic Laboratories reference clients, with positive results reported for three (11%): two with potential pathogens (West Nile virus and Toxoplasma gondii) and one with Streptococcus species with other bacteria below the reporting threshold (considered to represent contamination). Of 68 negative results, 10 included comments on decreased sensitivity due to high DNA background (n = 5), high RNA background (n = 1), insufficient RNA read depth (n = 3), or quality control (QC) failure with an external RNA control (n = 1). The overall positive-result rate was 15% (12/80), with 58% (7/12) of these interpreted as being inconsistent with the patient's clinical presentation. Overall, potential pathogens were found in a low percentage of cases, and positive results were often of unclear clinical significance. Testing was commonly employed in cases of diagnostic uncertainty and when immunotherapy was being considered.
引用
- Rodino KG, Toledano M, Norgan AP, et al. Retrospective Review of Clinical Utility of Shotgun Metagenomic Sequencing Testing of Cerebrospinal Fluid from a U.S. Tertiary Care Medical Center. J Clin Microbiol. 2020. PMID: 32938739. doi:10.1128/JCM.01729-20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。